SARS-COV-2: History, Genetics, and Treatment

Background and Aim: Coronaviruses are a large family of viruses that cause disease in humans and animals. Coronavirus Disease 2019 (COVID-19) is an acute respiratory infectious disease caused by a new coronavirus. The World Health Organization has declared this infectious disease as a global pandemi...

Full description

Bibliographic Details
Main Authors: Niloofar Agharezaei, Felora Forouzesh
Format: Article
Language:fas
Published: Arak Medical University 2020-11-01
Series:Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk
Subjects:
Online Access:http://jams.arakmu.ac.ir/article-1-6343-en.html
id doaj-5c055ee4cc0f4428bab11f393ea998a4
record_format Article
spelling doaj-5c055ee4cc0f4428bab11f393ea998a42021-05-26T10:49:11ZfasArak Medical UniversityMajallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk1735-53382008-644X2020-11-01235666685SARS-COV-2: History, Genetics, and TreatmentNiloofar Agharezaei0Felora Forouzesh1 Department of Genetics, Faculty of Advanced Science and Technologies, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. Department of Genetics, Faculty of Advanced Science and Technologies, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. Background and Aim: Coronaviruses are a large family of viruses that cause disease in humans and animals. Coronavirus Disease 2019 (COVID-19) is an acute respiratory infectious disease caused by a new coronavirus. The World Health Organization has declared this infectious disease as a global pandemic. Objective: This study aims to review the latest research advances in genetics, pathogenicity, and clinical features of COVID-19, as well as current therapies to combat this disease. Methods & Materials: This is a systematic review study on articles published from 2010 to 2020 by searching in reputable databases such as PubMed, Scopus, Google Scholar, Web of Science, and ScienceDirect. Ethical Considerations: Ethical principles have been observed in accordance with the guidelines of the National Ethics Committee and the COPE regulations. Results: Examining the genome and genetic studies of the virus, it can be said that there are many similarities between different coronavirus types, but there are differences in their genomic and phenotypic structures that can affect their pathogenesis. Re-use of existing therapeutic drugs, previously designed for other infections and viral pathologies is currently the only practical approach to fight COVID-19. The tests for SARS-CoV-2 genome-specific vaccines and the therapeutic antibodies are currently being tested, but they require a long-term process and complete safety testing. Conclusion: Rapid diagnosis of SARS-CoV-2 infection is the basis of disease control. There is currently no specific antiviral drug approved for SARS-CoV-2 infection. Therefore, preventive measures are necessary to stop and control the spread of COVID-19, according to genetic studies and the obtaining knowledge of the molecular mechanism of this virus.http://jams.arakmu.ac.ir/article-1-6343-en.htmlcoronavirus disease 2019geneticshistorypublic healthtreatment
collection DOAJ
language fas
format Article
sources DOAJ
author Niloofar Agharezaei
Felora Forouzesh
spellingShingle Niloofar Agharezaei
Felora Forouzesh
SARS-COV-2: History, Genetics, and Treatment
Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk
coronavirus disease 2019
genetics
history
public health
treatment
author_facet Niloofar Agharezaei
Felora Forouzesh
author_sort Niloofar Agharezaei
title SARS-COV-2: History, Genetics, and Treatment
title_short SARS-COV-2: History, Genetics, and Treatment
title_full SARS-COV-2: History, Genetics, and Treatment
title_fullStr SARS-COV-2: History, Genetics, and Treatment
title_full_unstemmed SARS-COV-2: History, Genetics, and Treatment
title_sort sars-cov-2: history, genetics, and treatment
publisher Arak Medical University
series Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk
issn 1735-5338
2008-644X
publishDate 2020-11-01
description Background and Aim: Coronaviruses are a large family of viruses that cause disease in humans and animals. Coronavirus Disease 2019 (COVID-19) is an acute respiratory infectious disease caused by a new coronavirus. The World Health Organization has declared this infectious disease as a global pandemic. Objective: This study aims to review the latest research advances in genetics, pathogenicity, and clinical features of COVID-19, as well as current therapies to combat this disease. Methods & Materials: This is a systematic review study on articles published from 2010 to 2020 by searching in reputable databases such as PubMed, Scopus, Google Scholar, Web of Science, and ScienceDirect. Ethical Considerations: Ethical principles have been observed in accordance with the guidelines of the National Ethics Committee and the COPE regulations. Results: Examining the genome and genetic studies of the virus, it can be said that there are many similarities between different coronavirus types, but there are differences in their genomic and phenotypic structures that can affect their pathogenesis. Re-use of existing therapeutic drugs, previously designed for other infections and viral pathologies is currently the only practical approach to fight COVID-19. The tests for SARS-CoV-2 genome-specific vaccines and the therapeutic antibodies are currently being tested, but they require a long-term process and complete safety testing. Conclusion: Rapid diagnosis of SARS-CoV-2 infection is the basis of disease control. There is currently no specific antiviral drug approved for SARS-CoV-2 infection. Therefore, preventive measures are necessary to stop and control the spread of COVID-19, according to genetic studies and the obtaining knowledge of the molecular mechanism of this virus.
topic coronavirus disease 2019
genetics
history
public health
treatment
url http://jams.arakmu.ac.ir/article-1-6343-en.html
work_keys_str_mv AT niloofaragharezaei sarscov2historygeneticsandtreatment
AT feloraforouzesh sarscov2historygeneticsandtreatment
_version_ 1721426305847656448